Traduction de «german » (Français → Néerlandais) :

TERMINOLOGIE

syndrome de German
syndroom van German

TRADUCTIONS EN CONTEXTE

“The official original document is in English language; German and French language versions are supplied for reference only”.
The official original document is in English language; German and French language versions are supplied for reference only.

DE - Hand-held laser processing devices – safety measures (in German) 02/02/2012
DE - Hand-held laser processing devices – safety measures (in German) 02-02-2012

[http ...]
[http ...]

− Gertz C, Matthäus B. Optimum Deep Frying Recommendations by the German Society for Fat Science, .
Gertz C, Matthäus B. Optimum Deep Frying Recommendations by the German Society for Fat Science, .

[20] S. Gress, A. Focke, F. Hessel, and J. Wasem, Financial incentives for disease management programmes and integrated care in German social health insurance., Health policy (Amsterdam, Netherlands), vol. 78, no. 2-3, pp. 295-305, Oct. 2006. [21] S. Gress, P. Groenewegen, J. Kerssens, B. Braun, and J. Wasem, Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands., Health policy, vol. 60, no. 3, pp. 235-54, Jun. 2002. [22] D. Grijpstra, S. Broek, B.-J.
44-55, 2001. [20] S. Gress, A. Focke, F. Hessel, and J. Wasem, Financial incentives for disease management programmes and integrated care in German social health insurance., Health policy (Amsterdam, Netherlands), vol.

[46] S. Stock et al., Financial incentives in the German Statutory Health Insurance: new findings, new questions., Health policy, vol. 96, no. 1, pp. 51-6, Jun. 2010. [47] S. Thomson, T. Foubister, J. Figueras, J. Kutzin, G. Permanand, and L. Bryndová, Addressing financial sustainability in health systems, 2009.
[46] S. Stock et al., Financial incentives in the German Statutory Health Insurance: new findings, new questions., Health policy, vol. 96, no. 1, pp.

Remerciements : Pour son aide précieuse relative à la méta-analyse : Cécile Dubois (KCE) Pour leur contribution au scoring des indicateurs : Raf Brouns et Matthieu Rutgers (Belgian Stroke Council) Pour la validation de la description de leur pays : Suède : Kiell Asplund (Chair, Risks Stroke Umea), Bo Norrving (Professor, Lund University-Steering committee member Riks stroke) Pays-Bas : Martien Limburg (Neuroloog, Flevoziekenhuis, Almere, Stichting Kennisnetwerk) Ecosse : Martin Dennis (Division of Clinical Neurosciences – Western General Hospital University of Edinburgh), Peter Langhorne (Professor of Stroke Care, Cardiovascular and Medical Sciences Division – University of Glasgow) Grande-Bretagne : Patrick Gompertz (Barts and the London Brain Attack Center, London), Gill Gluckie (Clinical lead, stroke, Guy’s and St. Thomas’ hospital, clinical lead, S/East London stroke network) France : France Woimant (Service de neurologie, hôpital Lariboisière, Paris – “Agence Régionale de Santé – Ilede-France”), Didier Leys (Département de neurologie, Hôpital universitaire de Lille) Allemagne : Peter Heuschmann (Neurologische klinik und poliklinik, Universitätsklinikum Würzburg) German Stroke Register Study Group), E. Bernd Ringelstein (Neurologische klinik und poliklinik, Universitätsklinikum Münster)
Acknowledgements: Voor haar waardevolle bijdrage in het gedeelte over meta-analyse: Cécile Dubois (KCE) Voor hun bijdrage bij het scoren van de indicatoren: Raf Brouns en Matthieu Rutgers (Belgian Stroke Council) Voor het valideren van de informatie over hun land: Zweden: Kiell Asplund (Chair, Risks Stroke Umeal), Bo Norrving (Professor, Lund University-Steering committee member Riks stroke) Nederland: Martien Limburg (Neuroloog, Flevoziekenhuis, Almere, Stichting Kennisnetwerk); Schotland: Martin Dennis (Division of Clinical Neurosciences – Western General Hospital University of Edinburgh), Peter Langhorne (Professor of Stroke Care, Cardiovascular and Medical Sciences Division – University of Glasgow) Verenigd Koninkrijk: Patrick Gompertz (Barts and the London Brain Attack Center, London), Gill Gluckie (Clinical lead, stroke, Guy’s and St. Thomas’ hospital, clinical lead, S/East London stroke network) Frankrijk: France Woimant (Service de neurologie, hôpital Lariboisière, Paris – “Agence Régionale de Santé – Ile-de-France”), Didier Leys (Département de neurologie, Hôpital universitaire de Lille) Duitsland: Peter Heuschmann (Neurologische klinik und poliklinik, Universitätsklinikum Würzburg) German Stroke Register Study Group), E. Bernd Ringelstein (Neurologische klinik und poliklinik, Universitätsklinikum Münster)

Les hôpitaux qui obtiennent l’agrément sont publiés sur une liste officielle, visible notamment sur le site de la German Stroke Society.
Ziekenhuizen die de erkenning krijgen, worden gepubliceerd op een officiële lijst, die ook terug te vinden is op de site van de German Stroke Society.

This is also shown by the gradual increase of embolic protection to 100% of all users in the prospective Carotid Artery Stent (CAS) Registry of the German Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). 37 Reviews including older technologies including unprotected stenting or angioplasty may underestimate the current Âstate of the artÊ of CAS.
This is also shown by the gradual increase of embolic protection to 100% of all users in the prospective Carotid Artery Stent (CAS) Registry of the German Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK).37 Reviews including older technologies including unprotected stenting or angioplasty may underestimate the current Âstate of the artÊ of CAS.

Les analyses, menées en collaboration avec le Centre allemand du cancer (German Cancer Research Center - DKFZ) et l’Institut national du cancer américain (National Cancer Institute - NCI) ont été effectuées rétrospectivement sur les échantillons de sang de plus de 500.000 personnes de 10 pays européens, qui avaient participé dans les années 1990 à une vaste étude sur les liens entre nutrition et cancer (EPIC).
De analyses verliepen in samenwerking met het Duitse Kankercentrum (German Cancer Research Center - DKFZ) en het Amerikaanse Nationaal Kanker Instituut (National Cancer Institute - NCI). Het ging om retrospectieve analyses van bloedstalen van meer dan 500 000 mensen uit 10 Europese landen.